Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 421.16M P/E - EPS this Y 34.20% Ern Qtrly Grth -
Income -220.4M Forward P/E -1.90 EPS next Y 20.30% 50D Avg Chg -6.00%
Sales 2.91M PEG - EPS past 5Y - 200D Avg Chg -40.00%
Dividend N/A Price/Book 1.76 EPS next 5Y - 52W High Chg -65.00%
Recommedations 2.20 Quick Ratio 6.83 Shares Outstanding 33.93M 52W Low Chg 15.00%
Insider Own 34.70% ROA -35.99% Shares Float 11.76M Beta 0.18
Inst Own 66.33% ROE -115.71% Shares Shorted/Prior 5.28M/5.78M Price 9.75
Gross Margin - Profit Margin - Avg. Volume 317,338 Target Price 19.10
Oper. Margin -4,095.46% Earnings Date Nov 11 Volume 334,541 Change -5.89%
About IGM Biosciences, Inc.

IGM Biosciences, Inc., a clinical-stage biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer and autoimmune and inflammatory diseases. It develops Aplitabart, a Death Receptor 5 Agonist IgM antibody for the treatment of colorectal cancer; imvotamab, a CD20 x CD3 bispecific IgM antibody to treat myositis, as well as for the treatment of systemic lupus erythematosus and rheumatoid arthritis that is Phase Ib clinical trial; and IGM-2644, a bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins for the treatment of autoimmune diseases. IGM Biosciences, Inc. has a collaboration and license agreement with Genzyme Corporation to generate, develop, manufacture, and commercialize IgM antibodies. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.

IGM Biosciences, Inc. News
11/10/24 IGM Biosciences Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
11/08/24 IGM Biosciences, Inc. (IGMS) Reports Q3 Loss, Tops Revenue Estimates
11/08/24 IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update
11/07/24 IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans
11/04/24 IGM Biosciences to Present at Three Upcoming Investor Conferences
10/01/24 These Stocks Moved the Most Today: APA, Northrop, Boeing, Super Micro, HP Inc., Tesla, Li Auto, CVS, Ford, and More
10/01/24 Top 1% Biotech, IGM Biosciences, Plummets On Scrapped Drug, C-Suite Makeover
10/01/24 IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO
10/01/24 IGM Biosciences Stock Drops Sharply on ‘Pipeline Transformation’ to Autoimmune Diseases
10/01/24 IGM lays off staff in autoimmune pivot; Metsera ramps up obesity drug supply
09/30/24 IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity
09/27/24 While shareholders of IGM Biosciences (NASDAQ:IGMS) are in the black over 1 year, those who bought a week ago aren't so fortunate
09/18/24 IGM Biosciences (IGMS) Surges 11.6%: Is This an Indication of Further Gains?
09/10/24 IGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation Summit
08/22/24 All You Need to Know About IGM Biosciences (IGMS) Rating Upgrade to Buy
08/14/24 IGM Biosciences, Inc. (IGMS) Reports Q2 Loss, Lags Revenue Estimates
08/14/24 IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update
07/12/24 IGM Biosciences (IGMS) Soars 32.7%: Is Further Upside Left in the Stock?
06/05/24 Shareholders May Find It Hard To Justify Increasing IGM Biosciences, Inc.'s (NASDAQ:IGMS) CEO Compensation For Now
05/30/24 We're Keeping An Eye On IGM Biosciences' (NASDAQ:IGMS) Cash Burn Rate
IGMS Chatroom

User Image Bornjever Posted - 6 hours ago

$ETNB $IGMS MYNZ is a very strong medical company in testing area and all of us could benefit from the technology and the investment. I am very excited in sober way and I hope for sake of all of us this comes to fruition for benefit of all.

User Image Solene__Frost Posted - 1 day ago

$ETNB $IGMS LFG, expected this to move higher. Also, your thoughts on MYNZ? Who's behind the 30M share offering deal? 👀 And how could the Thermo Fisher (TMO) partnership ($210B market cap) reflect this stock movement and PR buzz everywhere on socials?

User Image JohannaTurner Posted - 6 days ago

$ETNB $IGMS MYNZ Wow, this is insane news! Don't miss out. The train is leaving the station. Add it to your watchlist to see what happens next. 😏

User Image PenkeTrading Posted - 6 days ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of IGM Biosciences Inc. Is that bullish or bearish? $IGMS #RsiOversold #NASDAQ

User Image Selenashulav Posted - 1 week ago

$IGMS what’s the newest catalyst with this ticker in short term anyone has any analysis if then kindly like to hear .

User Image Truet67 Posted - 1 week ago

💥 Boom 🚨 Big news! LFGOOOOOO! Mainz Biomed MYNZ has teamed up with Thermo Fisher TMO (mkt cap $209.2B, trading at ~$546.92) to develop a next-gen colorectal cancer screening tool for global markets. Thermo Fisher’s $42.4B annual revenue and advanced tech will boost MYNZ’s mRNA-based assays, hitting 85% detection for advanced adenomas vs. competitors’ 43% and 20%. With CRC cases up 500% in young people, MYNZ is leading early detection. Win-win for both sides — TMO stepping into the CRC market too. Big developments ahead! Calling all apes, let's crush these shorties—this time is bull time. Insane news, we've been waiting for!!! $ETNB $IGMS

User Image Adelyn_Fish Posted - 1 week ago

MYNZ 🔥 Perfect time to jump in, cheapest dip!!! Shorts volume increased. Low Float only 29M outstanding shares. Any buy-in will make this fly to the moon. Here is why… 1.Frankie Muniz backing Mainz (yes, the Malcolm guy & NASCAR #33 now repping MYNZ). 2.Petra, ex-Obama advisor, hinted at a big U.S. lab partner. Solid source! 3.Six news hits in 3 weeks—momentum. 4.Already solid in the EU, not new but expanding, with insurance covering their tests. 5.Their test has 88% accuracy vs. EXAS (42%) & GH (20%)—big edge! 6.$1.5M private placement in the bag. 7.CEO teased big plans ahead. 8.Offering Deal $ETNB $IGMS

User Image JB_Research Posted - 1 week ago

$IGMS CEO: "imvotamab remains generating robust initial data sets in rheumatoid arthritis, systemic lupus erythematosus and myositis..." Cash runway confirmed 'till "into 2027" https://investor.igmbio.com/news-releases/news-release-details/igm-biosciences-announces-third-quarter-2024-financial-results

User Image DonCorleone77 Posted - 1 week ago

$IGMS IGM Biosciences reports Q3 EPS ($1.01), consensus (80c) Reports Q3 revenue $516,000, consensus $270k. "The third quarter was transformative for IGM, punctuated by the announcement of our strategic pivot to focus exclusively on autoimmunity," said Mary Beth Harler, M.D., Chief Executive Officer of IGM Biosciences. "Our near-term focus for imvotamab remains generating robust initial data sets in rheumatoid arthritis, systemic lupus erythematosus and myositis. Based on enrollment timing, we expect to have sufficient information by the middle of 2025 to present initial imvotamab data at an appropriate venue as well as determine next steps to advance imvotamab in autoimmune indications."

User Image Doozio Posted - 10/31/24

$IGMS who wants to drink some LMND during 🧠⏰♾️

User Image Secret_Stocks Posted - 10/29/24

@EquityInvest @Swayway3011 $igms made aa tons only a few shares left so that it can be on my radar. Revisit $8?

User Image BobBijawklah Posted - 10/25/24

$IBRX I like $ckpt $acad $igms . CKPT PDUFA resubmission Dec 28th. ACAD new CEO VP / general manager of $bmy IGMS rumblings that their auto immune compounds have a superior advantage over the current technology without any major SAEs.

User Image FinJay Posted - 10/23/24

Top 5 highest squeeze stocks in the market via short score. $RNAC $IGMS $SAVEQ $FTEL $SCLX https://youtu.be/SXvQiwi7yvo

User Image Doozio Posted - 1 month ago

$IGMS da FUTUre of 🧠⏰ is NOW during 🧠⏰♾️

User Image Doozio Posted - 1 month ago

$IGMS 🧠⏰♾️

User Image Swayway3011 Posted - 1 month ago

$IGMS

User Image JB_Research Posted - 1 month ago

$IGMS $XBI "RBC's reinforced conviction here stems from the strong mechanistic rationale behind Imvotamab's potential across various autoimmune indications. This optimism is fueled by the anticipation of near-term data..." https://www.investing.com/news/company-news/igm-biosciences-stock-target-increased-on-autoimmune-pivot-93CH-3670958

User Image Thestocktraderhubzee Posted - 1 month ago

$IGMS RBC Capital Maintains Outperform on IGM Biosciences, Raises Price Target to $20

User Image Botanical_Brian Posted - 1 month ago

$IGMS got out of short @ 14.75, will replay again @ 17.50

User Image JB_Research Posted - 1 month ago

$IGMS Technically a Buy right now... (as long as it closes above $13.83) https://stockinvest.us/stock/IGMS

User Image Botanical_Brian Posted - 1 month ago

$IGMS sub $14.50 close today?

User Image Botanical_Brian Posted - 1 month ago

$IGMS added 600+ more to my short position yesterday at close, 4802 total, looks like I'll be getting a Rolex and engraving IGMS on the back

User Image Botanical_Brian Posted - 1 month ago

$IGMS

User Image Botanical_Brian Posted - 1 month ago

$IGMS back down to the 13s by EOW

User Image Botanical_Brian Posted - 1 month ago

$IGMS going heavy short here...4,200+ shares and looking to add more

User Image MaverikIT Posted - 1 month ago

@IsabellaDC @net0trader @RonIsWrong $VKTX $TGTX - trying $IGMS

User Image Swayway3011 Posted - 1 month ago

$IGMS has been so good to me, first bought in at 10.98, sold at 20.89 even though it doesn’t show that high of a price on the chart. Then bought back in at 13.73, and still holding.

User Image Doozio Posted - 1 month ago

$IGMS da FUTUre of 🧠⏰ is NOW during 🧠⏰♾️

User Image Doozio Posted - 1 month ago

$FTEL $igms huckleberries n 🐑 🩳s during 🧠⏰♾️

User Image ientombu Posted - 1 month ago

$FTEL $IGMS $RNAC $RVPH $SAVEQ 98+% short score. Next week could get spicy!

Analyst Ratings
Guggenheim Buy Oct 1, 24
Wedbush Outperform Oct 1, 24
RBC Capital Outperform Oct 1, 24
JP Morgan Underweight Oct 1, 24
Truist Securities Hold Oct 1, 24
HC Wainwright & Co. Neutral Sep 5, 24
Truist Securities Buy Aug 23, 24
Wedbush Outperform Aug 15, 24
RBC Capital Outperform Aug 15, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Schwarzer Fred CEO and President CEO and President Dec 13 Sell 5.7782 17,576 101,558 102,848 12/15/23
Keyt Bruce Chief Scientific Off.. Chief Scientific Officer Dec 13 Sell 5.7782 7,574 43,764 129,551 12/15/23
Decker Lisa Lynn Chief Business Offic.. Chief Business Officer Dec 13 Sell 5.7782 4,369 25,245 35,632 12/15/23
BAKER BROS. ADVISORS LP Director Director Dec 13 Buy 6.26 532,693 3,334,658 3,390,323 12/15/23
Takimoto Chris H Chief Medical Office.. Chief Medical Officer Nov 29 Sell 6.213 1,180 7,331 53,562 12/01/23
Gauthier George Chief Commercial Off.. Chief Commercial Officer Nov 29 Sell 6.21 1,180 7,328 39,642 12/01/23
Decker Lisa Lynn Chief Business Offic.. Chief Business Officer Nov 29 Sell 6.213 1,180 7,331 40,001 12/01/23
Tahir Misbah Chief Financial Offi.. Chief Financial Officer Nov 27 Sell 5.06 1,337 6,765 49,608 11/29/23
Schwarzer Fred CEO and President CEO and President Nov 27 Sell 5.0592 1,337 6,764 120,424 11/29/23
Keyt Bruce Chief Scientific Off.. Chief Scientific Officer Nov 27 Sell 5.0592 933 4,720 137,125 11/29/23
Gauthier George Chief Commercial Off.. Chief Commercial Officer Oct 02 Sell 7.9463 935 7,430 39,082 10/03/23
Gauthier George Chief Commercial Off.. Chief Commercial Officer Jul 03 Sell 9.4209 936 8,818 40,017 07/05/23
Topsoe Christina Teng Director Director Jun 30 Buy 9.32 3,000 27,960 9,800 07/05/23
Redmile Group, LLC Director Director Jun 29 Sell 9.42 80,423 757,585 2,893,763 07/03/23
Redmile Group, LLC Director Director Jun 29 Buy 9.42 80,423 757,585 2,974,186 07/03/23
Topsoe Jakob Haldor Director Director Jun 29 Buy 9.17 7,000 64,190 81,644 07/03/23
BEHRENS M KATHLEEN Director Director Jun 26 Buy 8.00 112,500 900,000 330,700 06/28/23
Takimoto Chris H Chief Medical Office.. Chief Medical Officer May 23 Sell 12.65 1,259 15,926 54,742 05/25/23
Tahir Misbah Chief Financial Offi.. Chief Financial Officer May 23 Sell 12.65 1,259 15,926 50,711 05/25/23
Schwarzer Fred CEO and President CEO and President May 23 Sell 12.65 1,259 15,926 121,761 05/25/23
Keyt Bruce Chief Scientific Off.. Chief Scientific Officer May 23 Sell 12.65 982 12,422 138,058 05/25/23
Gauthier George Chief Commercial Off.. Chief Commercial Officer May 23 Sell 12.65 1,259 15,926 40,953 05/25/23
Decker Lisa Lynn Chief Business Offic.. Chief Business Officer May 23 Sell 12.65 1,259 15,926 41,181 05/25/23
Gauthier George Chief Commercial Off.. Chief Commercial Officer Apr 04 Sell 12.6 935 11,781 33,878 04/06/23
Takimoto Chris H Chief Medical Office.. Chief Medical Officer Mar 14 Sell 18.732 1,768 33,118 28,789 03/16/23
Tahir Misbah Chief Financial Offi.. Chief Financial Officer Mar 14 Sell 18.732 1,768 33,118 25,322 03/16/23
Keyt Bruce Chief Scientific Off.. Chief Scientific Officer Mar 14 Sell 18.732 1,293 24,220 90,704 03/16/23
Gauthier George Chief Commercial Off.. Chief Commercial Officer Mar 14 Sell 18.732 1,061 19,875 18,563 03/16/23
Decker Lisa Lynn Chief Business Offic.. Chief Business Officer Mar 14 Sell 18.732 1,061 19,875 16,732 03/16/23
Keyt Bruce Chief Scientific Off.. Chief Scientific Officer Jan 05 Option 0.93 33,756 31,393 91,997 01/09/23
Takimoto Chris H Chief Medical Office.. Chief Medical Officer Dec 16 Sell 19.07 5,430 103,550 30,557 12/20/22
Tahir Misbah Chief Financial Offi.. Chief Financial Officer Dec 16 Sell 19.38 6,084 117,908 27,090 12/20/22
Schwarzer Fred CEO and President CEO and President Dec 16 Sell 19.07 12,369 235,877 20,360 12/20/22
Keyt Bruce Chief Scientific Off.. Chief Scientific Officer Dec 16 Sell 19.07 5,371 102,425 58,241 12/20/22
Gauthier George Chief Commercial Off.. Chief Commercial Officer Dec 16 Sell 19.07 4,354 83,031 19,624 12/20/22
Decker Lisa Lynn Chief Business Offic.. Chief Business Officer Dec 16 Sell 19.07 2,484 47,370 17,793 12/20/22
Keyt Bruce Chief Scientific Off.. Chief Scientific Officer Dec 14 Option 0.93 25,000 23,250 63,612 12/16/22
Takimoto Chris H Chief Medical Office.. Chief Medical Officer Nov 23 Sell 21.68 877 19,013 35,987 11/28/22
Tahir Misbah Chief Financial Offi.. Chief Financial Officer Nov 23 Sell 21.68 877 19,013 33,174 11/28/22
Schwarzer Fred CEO and President CEO and President Nov 23 Sell 21.68 1,258 27,273 32,729 11/28/22
Keyt Bruce Chief Scientific Off.. Chief Scientific Officer Nov 23 Sell 21.68 877 19,013 38,612 11/28/22
Gauthier George Chief Commercial Off.. Chief Commercial Officer Nov 23 Sell 21.68 1,258 27,273 23,978 11/28/22
Decker Lisa Lynn Chief Business Offic.. Chief Business Officer Nov 23 Sell 21.68 1,258 27,273 20,277 11/28/22
Keyt Bruce Chief Scientific Off.. Chief Scientific Officer Oct 04 Option 0.93 25,000 23,250 64,489 10/06/22
Keyt Bruce Chief Scientific Off.. Chief Scientific Officer Oct 04 Sell 22.84 25,000 571,000 39,489 10/06/22
LOBERG MICHAEL D Director Director Sep 27 Buy 20.48 6,679 136,786 29,484 09/29/22
Keyt Bruce Chief Scientific Off.. Chief Scientific Officer Sep 06 Option 0.93 25,000 23,250 49,489 09/08/22
Keyt Bruce Chief Scientific Off.. Chief Scientific Officer Sep 06 Sell 19.5 25,000 487,500 39,489 09/08/22
Keyt Bruce Chief Scientific Off.. Chief Scientific Officer Aug 18 Option 0.93 25,000 23,250 45,789 08/22/22
Keyt Bruce Chief Scientific Off.. Chief Scientific Officer Aug 18 Sell 22.02 25,000 550,500 39,489 08/22/22